Roche withdraws Tecentriq from U.S. bladder cancer indication
ZURICH (Reuters) - Roche has voluntarily withdrawn the U.S. indication of Tecentriq for treating a form of bladder cancer following consultation with ...
Stay updated with breaking news from Michael Shields. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
ZURICH (Reuters) - Roche has voluntarily withdrawn the U.S. indication of Tecentriq for treating a form of bladder cancer following consultation with ...
ZURICH (Reuters) - The Swiss economy grew a real 0.2% in the third quarter versus the second three months of 2022 and 0.5% year-on-year, official data...
By Oliver Hirt, Noele Illien and Michael Shields ZURICH (Reuters) - Francesco De Ferrari, the head of Credit Suisse's wealth management business, is f...
By Oliver Hirt, Noele Illien and Michael Shields ZURICH (Reuters) - Francesco De Ferrari, the head of Credit Suisse's wealth management business, is f...
By Carolyn Cohn and Michael Shields ZURICH/LONDON (Reuters) -Zurich Insurance Group set more ambitious financial targets for the next three years on W...